Chlorpheniramine

xPharm: The Comprehensive Pharmacology Reference

Volumn , Issue , 2008, Pages 1-6

  Minigh, Jennifer ^a  

^a Medical Communication Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884039709     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008055232-3.61447-3     Document Type: Chapter

References (20)

1. Peets E.A., Jackson M., Symchowicz S. Metabolism of chlorpheniramine maleate in man. J. Pharmacol. Exp. Ther. 1972, 180:364-374.
2. Rumore M.M. Clinical pharmacokinetics of chlorpheniramine. Drug Intell. Clin. Pharm. 1984, 18:701-707.
3. Cook T.J., MacQueen D.M., Wittig H.J., Thornby J.I., Lantos R.L., Virtue C.M. Degree and duration of skin test suppression and side effects with antihistamines. A double-blind controlled study with five antihistamines. J. Allergy 1973, 51:71-77.
4. Gaddie J., Skinner C., Palmer K.N. Thymoxamine in bronchial asthma. Lancet 1972, 2:657.
5. Harvey R.P., Comer C., Sanders B., Westley R., Marsh W., Shapiro H., Wiener M. Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis. J. Allergy Clin. Immunol. 1996, 97:1233-1241.
6. Hedges A., Maclay W.P., Newman-Taylor A.J., Turner P. Some central and peripheral effects of meclastine, a new antihistamine drug, in man. J. Clin. Pharmacol. 1971, 11:112-119.
7. Huang S.M., Athanikar N.K., Sridhar K., Huang Y.C., Chiou W.L. Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults. Eur. Clin. Pharmacol. 1982, 22:359-365.
8. Melon J. Study of the activity of a new antihistamine, LM 209, on nasal reactions of allergic origin provoked by local administration of a sensitizing antigen. ARS Medici. 1974, 29:2473.
9. Thompson J.A., Bloedow D.C., Leffert F.H. Pharmacokinetics of intravenous chlorpheniramine in children. J. Pharm. Sci. 1981, 70:1284-1286.
10. Paton D.M., Webster D.R. Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines). Clin. Pharmacokinet. 1985, 10(6):477-497.
11. Huang S.M., Chiou W.L. Pharmacokinetics and tissue distribution of chlorpheniramine in rabbits after intravenous administration. J. Pharmacokinet. Bippharm. 1981, 9(6):711-723.
12. Fang S.Y., Druce H.M., Baraniuk J.N. Anticholinergic properties of bromopheniramine, chlorpheniramine, and atropine in human nasal mucosa in vitro. Am. J. Rhinol. 1998, 12(2):131-133.
13. Lai C.M., Stoll R.G., Look A.M. Urinary excretions of chlorpheniramine and pseudoephedrine in humans. J. Pharm. Sci. 1979, 68:1243-1246.
14. Piratello A.C., Mattioli R. Effects of chlorpheniramine and L-histidine on vestibular compensation in goldfish, Carassius auratus. Neurosci. Lett. 2004, 367(2):160-163.
15. Meltzer E.O., Berman G.D., Corren J., Pedinoff A.J., Doyle G., Waksman J.A., Butkerait P., Cooper S.A., Berlin R.G., Wason S. Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the treatment of seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 2004, 93(5):452-459.
16. Trissel L.A. Handbook on Injectable Drugs 1988, American Society of Hospital Pharmacists, Bethesda, MD. A.G. Gilman, L.S. Goodman, T.W. Rall (Eds.).
17. Chlorpheniramine. Product Information CHLOR-TRIMETON® 1999, Product Information Chlor-Trimetron, Schering-Plough Healthcare Products, Kenilworth, NJ.
18. Gilman A.G. Goodman and Gilman's The Pharmacological Basis of Therapeutics 1985, Macmillan Publishing Co, New York.
19. USP DI Volume I Drug information for the health care professional 2000, USPDI, Micromedex Inc., Taunton, MA. 20.
20. The Merck Index: an encyclopedia of chemicals, drugs, and biologicals 1989, The Merck Index, Merck Research Laboratories, Rahway, NJ. 11. S. Budavari (Ed.).